Abatement of the binding of human hexokinase II enzyme monomers by in-silico method with the design of inhibitory peptides.
Faranak KaramifardMahta MazaheriAli DadbinpourPublished in: In silico pharmacology (2024)
The online version contains supplementary material available at 10.1007/s40203-024-00201-8.